Fluconazole (Diflucan) and Nystatin Dosing for Fungal Infections
For most fungal infections requiring systemic therapy, fluconazole 200-400 mg daily (or 3-6 mg/kg/day) is the recommended dose, with treatment duration varying by infection type (7-21 days for most mucosal infections). For cutaneous candidiasis in skin folds, nystatin powder is typically applied 2-3 times daily, though specific maximum dose limits for topical nystatin powder are not established in the available guidelines 1, 2.
Fluconazole Dosing by Infection Type
The 2016 IDSA guidelines provide clear, evidence-based dosing recommendations:
Oropharyngeal Candidiasis (Oral Thrush)
- Mild disease: Topical therapy preferred (clotrimazole troches 10 mg 5 times daily OR nystatin suspension 100,000 U/mL, 4-6 mL 4 times daily for 7-14 days) 1
- Moderate to severe disease: Fluconazole 100-200 mg daily for 7-14 days 1
- FDA labeling confirms: 200 mg loading dose on day 1, then 100 mg daily for at least 2 weeks 2
Esophageal Candidiasis
- Fluconazole 200-400 mg (3-6 mg/kg) daily for 14-21 days 1
- FDA dosing: 200 mg day 1, then 100 mg daily (up to 400 mg/day based on response), minimum 3 weeks and at least 2 weeks after symptom resolution 2
Urinary Tract Candidiasis
- Fluconazole-susceptible organisms: 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
- FDA notes: 50-200 mg daily used in clinical practice 2
Systemic Candida Infections
- Doses up to 400 mg daily have been used, though optimal dosing not fully established 2
Vaginal Candidiasis
- Single dose: 150 mg orally once 2
Important Fluconazole Dosing Principles
Loading dose strategy: A loading dose of twice the daily maintenance dose on day 1 achieves steady-state concentrations more rapidly 2. This is particularly important for serious infections.
Oral = IV dosing: Due to rapid and nearly complete oral absorption, the daily dose is identical whether given orally or intravenously 2.
Nystatin for Cutaneous Candidiasis (Skin Folds)
The available evidence does not provide specific maximum dose recommendations for nystatin powder applied to skin folds. Based on clinical practice:
- Typical application: Apply to affected areas 2-3 times daily
- No established maximum dose for topical powder formulations in the guidelines reviewed
- For oral nystatin suspension (different formulation): 100,000 U/mL, 4-6 mL 4 times daily is used for oral candidiasis 1
Clinical Context for Nystatin Use
The guidelines emphasize nystatin's role primarily for:
- Mild oropharyngeal candidiasis (as suspension or pastilles)
- Alternative to azoles when resistance is present 3
- Topical application for localized superficial infections
Important caveat: For intertriginous (skin fold) candidiasis, while nystatin powder is commonly used in clinical practice, the IDSA guidelines focus primarily on systemic and mucosal infections rather than providing detailed topical therapy recommendations.
Key Clinical Considerations
Treatment duration matters: Inadequate treatment duration leads to recurrence 2. Continue therapy until clinical and laboratory evidence indicates infection resolution.
Fluconazole resistance: For fluconazole-refractory disease, alternatives include itraconazole solution 200 mg daily or posaconazole suspension 400 mg twice daily for 3 days then 400 mg daily 1. Nystatin may be effective for fluconazole-resistant Candida, particularly C. glabrata 3.
Species-specific considerations: C. glabrata and C. krusei may require alternative agents (amphotericin B or echinocandins) rather than fluconazole 1.